Arcutis Biotherapeutics, Inc. ARQT Other income, net (Note 6)
Other income, net (Note 6) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s other income, net (note 6)?
- Arcutis Biotherapeutics, Inc. (ARQT) reported other income, net (note 6) of -$20K in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s other income, net (note 6) changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s other income, net (note 6) decreased by 110.4% year-over-year, from $193K to -$20K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.